Ocular toxicity of systemic medications: A case series

Optometry

Volumn 71, Issue 1, 2000, Pages 29-39

  To, To Quyen H ^a,c   Townsend, John C ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

^c S California College of Optometry ^*  (United States)

Author keywords

Amiodarone; Chlopromazine; Glaucoma; Isoniazid (INH); Ocular toxicity; Optic neuropathy; Phenothiazine; Posterior subcapsular cataract; Steroids; Thioridazine; Toxic retinopathy; Visual fields; Vortex epitheliopathy

Indexed keywords

AMIODARONE; ISONIAZID; PREDNISONE; THIORIDAZINE;

ADULT; AGED; ARTICLE; CASE REPORT; CATARACT; CHEMICALLY INDUCED DISORDER; CORNEA DISEASE; EYE DISEASE; FEMALE; GLAUCOMA; HUMAN; MALE; MIDDLE AGED; OPTIC NEURITIS; PATHOLOGY; RETINA DISEASE; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD;

ADULT; AGED; AMIODARONE; CATARACT; CORNEAL DISEASES; EYE DISEASES; FEMALE; GLAUCOMA; HUMANS; ISONIAZID; MALE; MIDDLE AGED; OPTIC NEURITIS; PREDNISONE; RETINAL DISEASES; THIORIDAZINE; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 0033627910     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Karmon G, Savir H, Zevin D, et al. Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment. Ann Ophthalmol 1979;11:1013-7.
2. Tekell JL, Silva JA, Maas JA, et al. Thioridazine-induced retinopathy. Am J Psychiatry 1996;153:1234-5.
3. Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Derm Clin 1992;10:505-12.
4. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998;42:360-6.
5. Bartlett JD, Jaanus SD. Clinical ocular pharmacology. 3rd ed. Boston: Butterworth-Heinemann, 1995:Chapter 37.
6. Anonymous. Drugs for tuberculosis. Med Lett Drugs Ther 1995;37:67-70.
7. Donald PR, Sirgel FA, Botha FJ, et al. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am J Respir Crit Care Med 1997;156:895-900.
8. Schaberg T, Rebhan K, Lode H. Risk factors for side effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996;9:2026-30.
9. Jimenez-Lucho VE, Del Busto R, Odel J. Isoniazid and ethambutol as a cause of optic neuropathy. Eur J Respir Dis 1987;71:42-5.
10. Grant WM. Toxicology of the eye, 3rd ed. Springfield, Ill: Charles C. Thomas Publisher, 1986:82-3, 270-82, 536-8, 906-9.
11. Shah GK, Auerbach DB, Augsburger JJ, et al. Acute thioridazine retinopathy. Arch Ophthalmol 1998;116:826-7.
12. Kuna P. Long-term effects of steroid therapy. Wiadomosci Lekarskie (Polish) 1998;Suppl 1:12-8.
13. Silverman HM. The pill book, 7th ed. New York: Bantam Books, 1996:190-4.
14. Siddall JR. Ocular toxic changes associated with chlorpromazine and thioridazine. Can J Ophthalmol 1966;1:190-8.
15. Garbe E, Lelorier J, Boivin JF, et al. Risk of ocular hypertension or open-angle glaucoma in elderly patient on oral glucocorticoids. Lancet 1997;350:979-82.
16. Farber HJ, Sattigney W, Berenson G. Trends in asthma prevalence: the Bogalusa Heart Study. Ann Allergy Asthma Immunol 1997;78:265-9.
17. Bodner C, Ross S, Douglas G, et al. The prevalence of adult onset wheeze: longitudinal study. Br Med J 1997;314:792-3.
18. Platts-Mills TA. Rise in asthma. Science 1997;278:1001.
19. Flach AJ, Peterson JS, Dolan BJ. Anterior subcapsular cataracts: a review of potential etiology. Ann Ophthalmol 1985;17:78-80.
20. Flach AJ, Peterson JS, Sudduth G, et al. Amiodarone-induced lens opacities. Arch Ophthalmol 1983;101:1554-6.
21. D'Amico DJ, Kenyon KR, Ruskin JN. Amiodarone keratopathy. Drug induced lipid storage disease. Arch Ophthalmol 1981;99:257-61.
22. Dolan BJ, Flach AJ, Peterson JS. Amiodarone keratopathy and lens opacities. J AM OPTOM ASSOC 1985;54:468-70.
23. Nielsen CE, Andreasen F, Bjerregaard P. Amiodarone induced cornea verticillata. Acta Ophthalmol (Copenh) 1983; 61:474-80.
24. Gold Standard Multimedia Inc. (1996). Clinical Pharmacology: Isoniazid, Thioridazine, Prednisone, Amiodarone, Chlorpromazine [Online]. Available HTTP: http//webl.po.com/ html/www_pol_main/c.htm.
25. Jouveshomme S, Dautzenberg B. La chimiotherapie antituberculeuse. Rev Mal Respir (French) 1997; 14 Suppl 5: S88-104.
26. Hopewell PC. Prevention of lung infections associated with human immunodeficiency virus infection. Thorax 1989; 44:1038-44.
27. Fertel D, Pitchenik AE. Tuberculosis in Acquired Immunodeficiency Syndrome. Semin Respir Infect 1989;4:198-205.
28. Center for Disease Control. Diagnosis and management of mycobacterial infection and disease in persons with human immunodeficiency virus infection. Center for Disease Control, U.S. Department of Health and Human Resource. Ann Intern Med 1987; 106:254-6.
29. Hopewell PC. Tuberculosis and human immunodeficiency virus infection. Semin Respir Infect 1989;4:111-22.
30. Sutton PH, Beattie PH. Optic atrophy after administration of isoniazid with PAS. Lancet 1955;1:650-1.
31. Keeping JA, Searle CWA. Optic neuritis following isoniazid therapy. Lancet 1955;2:278.
32. Marmor MF. Is thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function. Br J Ophthalmol 1990;74:739-42.
33. Felderman JL, Gouras P, Schubert H, et al. Retina and vitreous. London: Mosby, 1997:16.3-16.4.
34. Kimbrough BO, Campbell RJ. Thioridazine levels in the human eye. Arch Ophthalmol 1981;99:2188-9.
35. Townsend JC, Selvin GJ, Griffin JR, et al. Visual fields: clinical case presentations. Boston: Butterworth-Heinemann, 1991:179-81.
36. Kaye LD, Kalenak JW, Price WC, et al. Ocular implications of long-term prednisone therapy in children. J Pediatr Ophthalmol Strabismus 1993;30:142-4.
37. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol 1963;70:482.
38. Francois J. Corticosteroid glaucoma. Ann Ophthalmol 1977; 9:1075.
39. Aggarwal RK, Potamitis T, Chong NH, et al. Extensive visual loss with topical facial steroids. Eye 1993;7(Pt 5):664-6.
40. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and risk of cataracts. N Engl J Med 1997;337:8-14.
41. Opatowsky I, Feldman RM, Gross RM, et al. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology 1995;102:177-9.
42. Williams KC, Barnebey HS. Meeting the challenge of secondary glaucomas. Rev Optom 1998;135:74-88.
43. Flach AJ, Dolan BJ. Progression of amiodarone induce cataracts. Doc Ophthalmol 1993;83:323-9.
44. Rivera RP, Younge BR, Dyer JA. Atypical amiodarone induced keratopathy in a patient wearing soft contact lenses. Contact Lens A O J 1989;15:219-21.
45. Kaplan LJ, Cappaert WE. Amiodarone keratopathy - correlation to dosage and duration. Arch Ophthalmol 1982; 100:601-2.
46. Feiner LA, Younge BR. Optic neuropathy and amiodarone therapy. Mayo Clin Proc 1987;62:702-17.
47. Mindel JM. Editorial: amiodarone and optic neuropathy - a medicolegal issue. Surv Ophthalmol 1998;42:358-9.
48. Borruat FX, Regli F. Pseudotumor cerebri as a complication of amiodarone therapy. Am J Ophthalmol 1993;116:776-7.